Erik Christopher Dreaden, PhD
Assistant Professor of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine
Assistant Professor of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine
Faculty, Winship Cancer Institute, Emory University
Faculty, Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology
The Dreaden Lab uses molecular engineering to augment and improve the function to cancer therapies and immunotherapies. Our primary interest in the use of molecular engineering is the realization of non-natural immune function – that is, function not achievable using either naturally occurring or genetically engineered biology – and the overall goal of our work is to develop synthetic biomolecules that can serve as both probes of fundamental cancer biology and as immunotherapies that are more tissue-exclusive and patient-personalized. Our lab currently focuses on the development of three main cancer technologies: optically-triggered cancer immunotherapies, combination therapies for pediatric malignancies, and nanometer scale cancer vaccine formulations.